25.01.2006 16:39:00
|
Fisher Scientific Chairman Emeritus Frank Jellinek Jr. Dies in Plane Crash
"All of us at Fisher are deeply saddened by the loss of our goodfriend. Our heartfelt sympathy and prayers go out to Frank's family,"said Paul M. Montrone, chairman and chief executive officer of FisherScientific International. "Frank was a great leader and an outstandingperson who dedicated his life to his family, company and community.Everyone who knew and worked with him was impressed by his passion forthe business and his warm personality. He will be greatly missed."
Jellinek was appointed chairman emeritus following the 2004 mergerof Apogent Technologies and Fisher Scientific International. Prior tothe merger, he served as chairman and chief executive officer ofApogent Technologies.
Jellinek was a veteran in the scientific-research industry withmore than 40 years of experience. In 1962, at the age of 15, he beganworking at Erie Scientific, a microscope slide company his grandfatherfounded.
Erie Scientific was sold to Sybron Corporation in 1969 andJellinek remained with the company, eventually becoming president ofSybron in 1998. In 2000, Sybron changed its name to ApogentTechnologies, and Jellinek was named president and CEO.
Born in Buffalo, N.Y., Jellinek earned a bachelor's degree inbusiness administration from Miami University in Ohio and an MBA fromCanisius College in New York.
Fisher Scientific: A World Leader in Serving Science
Fisher Scientific International Inc. (NYSE: FSH) is a leadingprovider of products and services to the scientific community. Fisherfacilitates discovery by supplying researchers and clinicians in labsaround the world with the tools they need. We serve pharmaceutical andbiotech companies; colleges and universities; medical-researchinstitutions; hospitals; reference, quality-control, process-controland R&D labs in various industries; as well as government agencies.From biochemicals, cell-culture media and proprietary RNAi technologyto rapid-diagnostic tests, safety products and other consumablesupplies, Fisher provides more than 600,000 products and services.This broad offering, combined with Fisher's globally integrated supplychain and unmatched sales and marketing presence, helps make our350,000 customers more efficient and effective at what they do.
Founded in 1902, Fisher Scientific is a FORTUNE 500 company and isa component of the S&P 500 Index. Fisher Scientific is a companycommitted to high standards and delivering on our promises -- tocustomers, shareholders and employees alike. Additional informationabout Fisher is available on the company's Web site atwww.fisherscientific.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Thermo Fisher Scientific Incmehr Nachrichten
30.01.25 |
S&P 500 aktuell: S&P 500 verbucht schlussendlich Zuschläge (finanzen.at) | |
30.01.25 |
NYSE-Handel: S&P 500 am Donnerstagmittag im Plus (finanzen.at) | |
30.01.25 |
Donnerstagshandel in New York: S&P 500 beginnt Donnerstagshandel im Plus (finanzen.at) | |
29.01.25 |
Ausblick: Thermo Fisher Scientific präsentiert Bilanzzahlen zum jüngsten Jahresviertel (finanzen.net) | |
27.01.25 |
S&P 500-Wert Thermo Fisher Scientific-Aktie: So viel Gewinn hätte eine Investition in Thermo Fisher Scientific von vor 5 Jahren abgeworfen (finanzen.at) | |
20.01.25 |
S&P 500-Titel Thermo Fisher Scientific-Aktie: So viel hätte eine Investition in Thermo Fisher Scientific von vor 3 Jahren gekostet (finanzen.at) | |
15.01.25 |
Erste Schätzungen: Thermo Fisher Scientific zieht Bilanz zum jüngsten Jahresviertel (finanzen.net) | |
13.01.25 |
S&P 500-Titel Thermo Fisher Scientific-Aktie: Hätte sich eine Thermo Fisher Scientific-Anlage vor einem Jahr inzwischen bezahlt gemacht? (finanzen.at) |
Analysen zu Thermo Fisher Scientific Incmehr Analysen
Aktien in diesem Artikel
Thermo Fisher Scientific Inc | 575,00 | -1,59% |